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Abstract
Although it is well accepted that air pollution exposure exacerbates
preexisting airway disease, it has not been firmly established
that long-term pollution exposure increases the risk of new-onset
asthma or chronic obstruction pulmonary disease (COPD).
This Workshop brought together experts on mechanistic,
epidemiological, and clinical aspects of airway disease to review
current knowledge regarding whether air pollution is a causal factor
in the development of asthma and/or COPD. Speakers presented
recent evidence in their respective areas of expertise related to air
pollution and new airway disease incidence, followed by interactive
discussions. A writing committee summarized their collective
findings. The Epidemiology Group found that long-term exposure
to air pollution, especially metrics of traffic-related air pollution such
as nitrogen dioxide and black carbon, is associated with onset of
childhood asthma. However, the evidence for a causal role in adult-
onset asthma or COPD remains insufficient. The Mechanistic
Group concluded that air pollution exposure can cause airway
remodeling, which can lead to asthma or COPD, as well as
asthma-like phenotypes that worsen with long-term exposure to
air pollution, especially fine particulate matter and ozone. The
Clinical Group concluded that air pollution is a plausible
contributor to the onset of both asthma and COPD. Available
evidence indicates that long-term exposure to air pollution is a
cause of childhood asthma, but the evidence for a similar
determination for adult asthma or COPD remains insufficient.
Further research is needed to elucidate the exact biological
mechanism underlying incident childhood asthma, and the
specific air pollutant that causes it.
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Overview
This workshop was convened to evaluate
the evidence regarding outdoor air
pollution as a causal factor in the
development of new-onset asthma and/or
chronic obstructive pulmonary disease
(COPD). The available evidence on
epidemiological associations, biological
mechanisms, and clinical considerations
was evaluated. Workshop participants
presented the current state of the
science in their respective fields, based
on their expertise and review of the
latest research available. Key conclusions
and recommendations included the
following:
d The weight of the evidence is consistent
with a causal relationship between new
onset of childhood asthma and long-term
exposure to outdoor air pollution,
especially metrics of traffic-related air
pollution (TRAP), such as nitrogen
dioxide (NO2) and black carbon (BC).
d It is unclear whether direct effects
of NO2 (the best-studied TRAP
component in epidemiologic studies)
or other components of TRAP,
such as fuel combustion particles
(implicated in toxicologic animal
studies), explain the causal link with
asthma.
d Further studies are needed to
determine whether the relationships
found in TRAP studies can be
generalized to air pollution from
other combustion sources, and to assess
the impact of air pollution on the
development of adult-onset asthma and/
or COPD.
d The reduced incidence of new onset
of childhood asthma should be
included in future assessments of the
health and monetary benefits of lessening
exposures to air pollution, especially
TRAP.
Introduction
Acute exacerbation of existing
respiratory diseases by air pollution
is well established and is commonly
factored into the decision-making
process of policymakers. For example,
short-term outdoor air pollution
exposures, including fine particulate
matter (particulate matter less than or
equal to 2.5 mm in aerodynamic
diameter [PM2.5]) (1), ozone (O3) (2),
NO2 (3), and sulfur dioxide (4) have
been accepted by the U.S. Environmental
Protection Agency as causally related
to acute adverse respiratory health
effects. The effects of air pollution
on asthma include acute associations
with increased symptoms (5), rescue
medication use (6), school absences
(7, 8), emergency department visits
(9, 10), hospitalizations (11, 12),
asthma lung function deficits (13–15),
and airway hyperresponsiveness (16),
Similarly, documented adverse
COPD health associations with
short-term PM2.5 exposures include
reduced pulmonary function (17) and
increased emergency room visits
(18), hospital admissions (19), and
mortality (20).
Compared with acute exposures
and health effects, it has been more
challenging to study and evaluate
the effects of long-term exposure on
incident disease; thus, less evidence
has been available in the published
literature. However, there is growing
evidence that long-term outdoor air
pollution exposures may also cause new
onset of airway disease. This Workshop was
convened to evaluate the evidence of
outdoor air pollution as a causal factor in the
development of new-onset asthma and/or
COPD.
Methods
At the annual American Thoracic Society
(ATS) International Conference in May
2018, a cross-disciplinary group met to
evaluate the evidence regarding the potential
role of air pollution in the onset of new
airway disease. The group included
researchers experienced in the mechanistic
aspects of airway disease development, air
pollution epidemiologists, and clinicians
with expertise in airway disease pathology/
diagnosis. Participants presented the current
state of the science in their respective fields,
based on their expertise and a review of
latest research available on their specific
topics. This is a consensus document, rather
than a formal systematic examination of all
the evidence. Consensus was reached by
majority vote. A writing committee
summarized the Workshop findings, which
all participants could review for an accurate
reflection of the proceedings. Potential
conflicts of interest were handled in
accordance with the policies and procedures
of the ATS.
We focused on the development of
new-onset asthma or COPD related to
outdoor air pollution exposure by
addressing several key questions:
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d Does the available epidemiologic
evidence concerning long-term air
pollution exposure support an association
with new-onset asthma or COPD?
d Are there biological mechanisms by
which air pollution could plausibly cause
new asthma or COPD?
d Are the health effects of air pollution
identified through epidemiologic and
mechanistic studies consistent with the
diagnosis of new asthma or COPD in a
clinical setting?
d Is there sufficient overall evidence to
conclude that long-term exposure to air
pollution contributes to the induction of
new asthma and/or COPD?
In this Workshop report, we first
summarize the epidemiological associations
found to date, and then assess whether these
associations are biologically and/or clinically
plausible.
Epidemiological Evidence
Air Pollution and New-Onset Asthma
Epidemiologic evidence linking exposure to
air pollution with the development of new-
onset asthma has grown in recent years.
Many studies have focused on surrogate
metrics of TRAP, as well as individual
ambient air pollutants. Commonly studied
TRAP components include nitrogen oxides,
NO2, BC, PM2.5, and PM less than or equal
to 10 mm in aerodynamic diameter (PM10).
Nitrogen Oxides, BC, PM2.5, and Other
Traffic-related Pollution
TRAP studies in children. TRAP exposures
were previously evaluated as a cause of
childhood or adult-onset asthma in Health
Effects Institute (HEI) Special Report 17
(21). This 2010 publication concluded that
living near busy roads is a risk factor for
onset of childhood asthma, but the data were
insufficient to conclude causality. Several
studies on the topic have been published
since the release of that report. For example,
the Southern California Children’s Health
Study (CHS) found an increased risk of new-
onset childhood asthma from TRAP at
home residences (22). Khreis and colleagues
subsequently synthesized 41 studies that
focused on children’s TRAP exposures as a
potential cause for asthma development
(23), and found associations with TRAP
metrics, especially NO2. (Figure 1). A 2017
meta-analysis of 18 studies of prenatal air
pollution exposures and childhood asthma
similarly found associations for NO2 and
PM10 (24). Findings were null for O3 and
PM2.5 mass (perhaps indicating that effects
varied by the PM2.5 constituent or source).
Other primary studies indicated that TRAP,
including prenatal exposure, contributes to
childhood asthma development (25–33).
In addition, in the United States, Latino
and black populations disproportionately
live in neighborhoods with higher air
pollution levels (34). Puerto Ricans and
black individuals have a higher prevalence
of asthma than white individuals (35).
The largest study of air pollution and
incident childhood asthma in U.S.
minorities found that early-life NO2
exposure was associated with childhood
asthma in Latinos and African Americans
(36). Since this Workshop was convened,
a multilevel longitudinal study drawn
from three waves of the CHS over a
decade of air pollution decline found
that decreases in ambient NO2 and
PM2.5 between 1993 and 2014
were significantly associated with lower
asthma incidence (37). This study is
consistent with an inference of causality
in the association between air pollution
and asthma incidence, as an intervention
to reduce exposure was followed by a
reduction in disease incidence.
TRAP studies in adults. A review and
meta-analysis of cohort studies found a
positive association between NO2 exposure
and asthma incidence in adults, but was based
on only three studies (38). Another review
found that the evidence was insufficient to
support a causal role for ambient air pollution,
but was qualitatively consistent with a role for
TRAP in the development of adult-onset
asthma (39). A Canadian study determined
that living near a major road was associated
with increased odds of new-onset asthma (40).
In the U.S. Sister Study (a large cohort of
U.S. women), incident asthma was positively
associated with PM2.5 and NO2, and both
pollutants were significantly positively
associated with incident wheeze, the cardinal
symptom of asthma (41). The ESCAPE
(European Study of Cohorts for Air Pollution
Effects) study, a meta-analysis involving six
European cohorts, reported positive
associations between TRAP and adult-onset
asthma (42), with several approaching
statistical significance, including NO2,
nitrogen oxides, and traffic intensity on
the nearest road. Two meta-analyses of
adult-onset asthma reported positive
associations with NO2 (13, 23), but only one
reached statistical significance (43). Since then,
there have been four studies in adult
populations (40, 44, 45). The largest of these
adult studies found a significant hazard ratio
for NO2 (45).
Overall, studies of new-onset asthma
and TRAP pollutants indicate the most
consistent positive relationship with NO2
exposure among children, but it remains
unclear whether NO2 itself is the causal
agent, simply has less measurement error
than other TRAP components, and/or is
simply a proxy for the combustion
component of TRAP (e.g., fossil fuel
combustion PM).
Ozone
There is extensive evidence that O3 exposure
acutely exacerbates asthma, but less support
for the hypothesis that long-term exposure
causes incident asthma. In a study of long-term
exposures, O3 was associated with new-onset
asthma in adult male Seventh-day Adventists
(46). A study in Taiwan indicated an
association between O3 exposure and risk of
childhood asthma (47). Also, the California
CHS found that in communities with high O3
concentrations, the relative risk of developing
asthma was increased in children who played
three or more sports as compared with
children who played no sports (48). However,
prenatal exposure toO3 has not been associated
with subsequent childhood asthma (24). Still,
the ambient quenching of O3 by traffic-
emitted nitric oxide (49) can cause a
negative correlation between O3 and NO2,
potentially confounding the relationships
between O3 and respiratory outcomes in
epidemiologic models.
Potential PM Composition Influences
Exposure to PM air pollution has been
associated with chronic airway diseases,
including asthma (23, 30, 41). In a study of
TRAP and new-onset asthma in a high-risk
cohort, Carlsten and colleagues found that,
among the TRAP pollutants considered,
PM2.5 was the air pollutant most strongly
associated with new-onset childhood asthma
(50). PM, however, varies greatly in chemical
composition as a function of its size and
source (1). Also, traffic-related PM (indicated
by BC) was found to be significantly related
to an increased risk of new-onset asthma in
children (23) (Figure 2). Although the
investigators of the PIAMA (Prevention and
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Incidence of Asthma and Mite Allergy) birth
cohort identified traffic as the major
contributing factor in their study area, PM2.5
sulfur, a marker for fossil fuel combustion,
generally had the largest relative risk for
incident asthma among several PM
constituents examined (51), so the PM2.5 and
BC associations reported may not be specific
to TRAP only.
Conclusions Regarding the
Epidemiology of New-Onset Asthma
d Overall, long-term exposure to air
pollution, especially as represented by
common metrics of TRAP exposure, is
associated with onset of childhood
asthma.
d The strongest epidemiologic evidence
for a causal relationship with new-
onset childhood asthma comes from
studies that used NO2 as the TRAP
metric.
d Evidence suggests that TRAP plays a role
in adult-onset asthma, but it is not yet
compelling.
d Greater effects likely occur in subgroups
(e.g., genetically susceptible individuals
and minorities).
d NO2 may be acting as a marker for PM
secondary to combustion of fossil fuels,
other reactive gases, or other nontailpipe
TRAP pollutants.
Air Pollution and New-Onset COPD
The potential role of air pollution in COPD
onset was addressed in a 2010 ATS review
(52) and an HEI report (21). The ATS
review concluded that there was limited/
suggestive evidence, and the HEI report
concluded that there was insufficient
evidence of a causal association between
TRAP and COPD.
Study or Subgroup log[Odds Ratio] SE Weight
Odds Ratio
IV, Random, 95% CI
Odds Ratio
IV, Random, 95% CI
Carlsten et al. 2010 - at 7 y.o. 0.2253
0.0489
0.1374
0.0397
0.0665
0.0874
0.0698
0.0877
0.1111
0.0698
0.0632
0.0289
0.1136
0.0153
0.574
–0.0679
–0.0252
–0.0214
–0.0359
0.039
0.1448
0.0171
0.0689
0.0498
0.0246
0.033
0.069
0.0215
0.1268
0.0281
0.0269
0.0701
0.0534
0.0048
0.2374
0.1235
0.0602
0.0219
0.0196
0.04
1.25 [0.94, 1.66]
1.05 [1.02, 1.09]
1.04 [0.96, 1.12]
1.15 [1.00, 1.31]
1.04 [0.94, 1.15]
1.07 [1.02, 1.12]
0.93 [0.73, 1.19]
0.98 [0.87, 1.10]
1.09 [1.02, 1.16]
0.98 [0.94, 1.02]
1.07 [0.94, 1.23]
1.09 [1.05, 1.14]
1.12 [0.87, 1.43]
1.07 [1.01, 1.13]
1.78 [1.11, 2.83]
1.07 [1.01, 1.12]
0.96 [0.93, 1.00]
1.03 [0.90, 1.18]
1.12 [1.01, 1.24]
1.02 [1.01, 1.03]
1.05 [1.02, 1.07]
0.5 0.7
Decreased risk Increased risk
1 1.5 2
100.0%
0.6%
9.5%
2.4%
3.8%
7.8%
6.1%
2.3%
8.5%
0.8%
7.1%
7.3%
2.3%
3.5%
11.6%
0.2%
0.8%
2.9%
8.4%
8.9%
5.0%Dell et al. 2014 LUR - 5 to 9 y.o.
Deng et al. 2016 - 3 to 6 y.o.
Jerret et al. 2008 - 10 to 18 y.o.
Kim et al. 2016 - 6 to 7 y.o.
Nishimura et al. 2013 - 8 to 21 y.o.
Oftedal et al. 2009 - birth to 10 y.o.
Ranzi et al. 2014 - birth to 7 y.o.
Shima et al. 2002 - 6 to 12 y.o.
Tétreault et al. 2016 - birth to 12 y.o.
Total (95% CI)
Heterogeneity: Tau2 = 0.00; Chi2 = 54.38, df = 19 (P < 0.0001); I2 = 65%
Test for overall effect: Z = 3.76 (P = 0.0002)
Krämer et al. 2009 - 4 to 6 y.o.
Liu et al. 2016 - 4 to 6 years old
Maclntyre et al. 2014 - CAPPS&SAGE only birth to 8
McConnell et al. 2010 - 4th to 6th grade
Mölter et al. 2014 b - MAAS only birth to 8 y.o.
Gehring et al. 2015 b - BAMSE birth to 16 y.o.
Gehring et al. 2015 b - PIAMA birth to 14 y.o.
Gehring et al. 2015b - GINI&LISA North birth to 15
Gehring et al. 2015b - GINI&LISA South birth to 15
Clark et al. 2010 LUR - at mean age of 4 y.o.
Figure 1. Meta-analysis of studies of nitrogen dioxide and new-onset asthma in children. Reprinted by permission from Reference 23. CI = confidence
interval; I2 = percentage of variation across studies due to heterogeneity; IV = instrumental variable; SE= standard error.
Study or Subgroup
Caristen et al. 2010 - at 7 y.o. 0.0397
0.0655
– 0.0105
0.1662
0.124
0.0322
0.14842
0.4293
0.1061
0.0312
0.1707
0.0804
0.1831
0.2613
0.14567461
0.344
6.3%
73.1%
2.4%
11.0%
2.1%
1.0%
3.4%
0.6%
100.0%
1.04 [0.85, 1.28]
1.07 [1.00, 1.14]
0.99 [0.71, 1.38]
1.18 [1.01, 1.38]
1.13 [0.79, 1.62]
1.03 [0.62, 1.72]
1.16 [0.87, 1.54]
1.54 [0.78, 3.01]
1.08 [1.03, 1.14]
Decreased risk Increased risk
0.5 0.7 1 1.5 2
Clark et al. 2010 LUR - at mean age of 4 y.o.
Gehring et al. 2015 b - BAMSE birth to 16 y.o.
Gehring et al. 2015  b - PIAMA birth to 14 y.o.
Gehring et al. 2015b - GINI&LISA South birth to 15
Gehring et al. 2015b - GINI&LISA North birth to 15
Krämer et al. 2009 - 4 to 6 y.o.
Mölter et al. 2014 b -MAAS only birth to 8 y.o.
Total (95% CI)
Heterogeneity: Tau2 = 0.00; Chi2 = 3.13, df = 7 (P = 0.87); I2 = 0%
Test for overall effect: Z = 2.96 (P = 0.003)
log[Odds Ratio] SE Weight
Odds Ratio
IV, Random, 95% CI
Odds Ratio
IV, Random, 95% CI
Figure 2. Meta-analysis of black carbon soot associations with new-onset asthma. Reprinted by permission from Reference 23. CI =confidence interval;
I2 =percentage of variation across studies due to heterogeneity; IV= instrumental variable; SE=standard error.
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Since the publication of those reviews, a
few new COPD studies have emerged. Some
included new onset of chronic bronchitis
symptoms and/or emphysema as COPD
surrogates, and found positive (but not
statistically significant) associations with air
pollution (53, 54). An analysis of the
European Community Respiratory Health
Cohort yielded significant associations
between NO2 and chronic bronchitis (55).
The ESCAPE study found significant
associations between COPD incidence
and TRAP among females (56). Most
studies that assessed COPD using
spirometry revealed positive associations
with NO2 and/or PM2.5 (45, 57–60). One
study investigated the development of
asthma and COPD overlap syndrome
(ACOS) in patients with asthma, and found
a significant association between long-term
PM2.5 exposure and ACOS development
(60). Associations found between indoor
exposures to biomass pollution and
increased risk of COPD, albeit at
much higher than usual ambient PM2.5
levels, are consistent with an association
between fine PM and the development of
COPD (61).
Only a limited number of studies have
examined the associations between O3 and
COPD. A study of adults >40 years of age
found no association between COPD
development and O3 (58). A survey-based
study of 6,040 adults found that O3 exposure
was associated with the development of
ACOS in adults with asthma (60), but the
association was nonsignificant after
adjustment for PM2.5. However, because the
large hospital databases or survey cohorts
used in these studies lacked important
individual risk factors, the results should be
interpreted with caution. Overall, there is
little firm evidence that O3 causes new-onset
COPD.
Conclusions Regarding the
Epidemiology of New-Onset COPD
d Studies indicated that exposure to traffic
has adverse effects on COPD, but were
not conclusive. The strongest evidence
comes from meta-analyses of COPD, and
few longitudinal studies have been
conducted.
d Overall, the available epidemiological
evidence regarding an association
between air pollution and new-onset
COPD remains insufficient to indicate a
causal relationship.
Mechanistic Evidence
A key factor that should be considered in
evaluating the causality of the above-
discussed epidemiological associations is
their biological plausibility (62, 63). The
mechanistic literature regarding air
pollution and asthma includes animal
models and exposure paradigms, but only a
few such studies have focused on COPD.
Several mechanisms can plausibly explain
how air pollution can induce new-onset
airway disease with implications for both
asthma and COPD, including 1) structural
remodeling of lung components,
predisposing to respiratory disease; 2)
induced immune changes, promoting
allergic sensitization or prolonged
inflammation; 3) changes in innate
cells (e.g., group 2 innate lymphoid cells
[ILC2]) in nonatopic asthma; and 4) other
modifiers of exposure, including genetics
and stress.
Repeated inflammation and long-term
air pollution exposure leads to airway
remodeling. Early-life changes, including
airway remodeling and oxidant stress, can be
related to the onset of COPDor asthma, which
may further progress to COPD (64). The
conducting airways are an epithelial
mesenchymal trophic unit (65) composed of
airway epithelium, extracellular matrix, and
fibroblasts, which interacts with nerves,
smooth muscle, and immune cells. These
elements grow interactively in a progressive
fashion that may be disturbed by air pollution
exposure. Alveolar growth and septation occur
through young adulthood (66, 67), providing
a substantial window of opportunity for air
pollution–induced disruption.
Asthma Development
Animal studies have demonstrated that
early-life air pollution exposures alter
conducting airway and alveolar growth
(68–70). Air pollutants impact alveolar
growth by pre- and postnatal exposures
in mice (71), as well as by postnatal
exposures in primates (72). Evidence
strongly suggests that the cellular
mechanism underlying this altered
growth involves decreased cellular
proliferation (73). In nonhuman primates,
which have a postnatal maturation pattern
and lung anatomy similar to those of
humans, O3 (70) and O3 plus allergic
sensitization to allergen induce substantial
airway (74) and alveolar (75) remodeling
during the early postnatal period. These
changes include alterations in smooth
muscle, innervation, mucous cell
abundance, and allergic sensitization
linked to airway hyperresponsiveness
(76). The most oxidizing particles,
similarly to traffic combustion
particles, change airway and/or lung
size (68, 69). Thus, oxidant stress may
be a common link with reduction in
lung growth.
Numerous studies have demonstrated
pulmonary responses to oxidant stress
after exposure to air pollution. These
responses occur in mice and rats with
long-term exposure to particulate air
pollution (77, 78), diesel exhaust (79–81),
iron soot (82), and ambient PM (83),
with changes in the antioxidant enzymes
8-hydroxydeoxyguanine (8-OHdG) and
glutathione/oxidised glutathione (GSH/
GSSG), and oxidation of lipids. Increases in
tissue expression of antioxidant genes and
proteins are a common response to long-
term exposure. Treatment with antioxidants
blunts the oxidant effects of particles
(84, 85), but early-life responses to
oxidant stress may differ from those
observed in adults (86). In neonatal
rats exposed to polycyclic aromatic
hydrocarbon–laden ultrafine PM,
which is similar to traffic PM,
antioxidant gene and protein expression
was not upregulated to levels similar
to those observed in adults (87–89).
There may be critical windows of time
during postnatal lung development
when antioxidant defenses are less able
to upregulate.
Early-Life Exposure Causes Immune
Changes, Including Type 1/Type 2
Skewing
Early-life air pollution exposure
promotes allergic sensitization. PM
components, such as diesel emission
particles (DEP) (90–93), ultrafine particles
(94–96), and PM2.5 (97–99), can act as
allergen-like adjuvants. Such particles have
redox-active metals, can induce
inflammation and oxidative stress, shift
immune function from a T-helper cell type 1
(Th1) to a Th2 response, and drive
lymphocyte proliferation and IgE
production.
Particle chemical composition is
important to biologic potency (99, 100).
Simultaneous intranasal administration
of ultrafine carbon black particles (CBP)
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and allergen (95), has demonstrated
increased adjuvant activity. Thus, CBP
can directly stimulate dendritic cell
maturation (94). DEP and residual
oil fly ash (ROFA) can act as adjuvants
to increase IgE, bronchoalveolar lavage
eosinophilia, lymphocyte reactivity,
Th2 cytokine (interleukin-5 and tumor
necrosis factor) production, cholinergic
airway responses, and allergen-induced
bronchoconstriction (95), as can
hydrocarbons and soluble transition metals
present in DEP and residual oil fly ash,
respectively. Thus, DEP and ultrafine
particles (UFP) can act as adjuvants in the
initial events of allergen sensitization,
increasing cytokine production,
inflammation, airway hyperresponsiveness
(AHR), and airways obstruction.
The role of oxidant stress as a link
between air pollution and asthma onset is
also supported by studies showing
susceptibility based on functional genetic
variants in pathways predicted by
mechanistic toxicology. For example,
Salam and colleagues found that epoxide
hydrolase 1 and glutathione-S-transferase
variants contribute to the occurrence
of childhood asthma and increase
asthma susceptibility to pollution
exposures from major roads (101). The
roles of these enzymes in asthma stem
from their function in important xenobiotic
metabolic pathways and the subsequent
oxidant stress–mediated tissue damage that
can contribute to the pathogenesis of asthma.
A Mechanism for Nonatopic Asthma
Consistent with air pollution–induced
nonatopic asthma, mice repeatedly exposed
to O3, without allergen exposure, were found
to develop nasal type 2 immunity and
eosinophilic rhinitis with mucous cell
metaplasia (Figure 3) (102). These O3-
induced airway alterations are mediated by
ILC2s, rather than by the more classical T
and B lymphoid cells that are important in
adaptive immune responses typically
associated with allergic rhinitis and allergic
asthma (103). Furthermore, repeated
exposure to O3 induces ILC2-mediated
airway type 2 immunity, eosinophilic
inflammation, and mucous cell metaplasia in
the pulmonary airways (104, 105). Thus,
repeated O3 exposures may induce a
nonatopic asthma phenotype characterized
by innate type 2 immunity, eosinophilic
inflammation, and mucous cell
metaplasia. These findings provide
plausible paradigms for biological
mechanisms underlying the
epidemiologically identified associations
between airway eosinophilic inflammation
and new onset of nonatopic asthma
(106, 107). In addition, after this
Workshop was conducted in May 2018,
another study evaluated the current scientific
evidence of a causal link between DEP and
asthma, and found consistent evidence of
physiological mechanisms by which DEPs
can cause new asthma (108).
COPD Development
Relatively few toxicological studies
have focused on COPD and air
pollution, as most animal models
replicate only a few COPD features,
and are expensive, technologically
challenging, and time-consuming
(109, 110). One recent development
is spontaneously hypertensive rats
that require less time (14 wk vs. 6 mo)
to induce COPD-like changes (111).
A ferret model developed airway
obstruction characteristic of bronchitis and
bronchiolitis (112). Short-term PM
exposures caused increased pulmonary
injuries and attenuated lung antioxidant
responses in spontaneously hypertensive
rats, providing further evidence of this
model’s sensitivity to respiratory changes
(113). Long-term exposures to O3 or
diesel exhaust are known to induce
Daily exposures to Ozone
Mucous cell
metaplasia
hyperplasia
hypertrophy
hyalinosis
Epithelial cell death
Key Events in Ozone-
Induced Murine Rhinitis and
Nasal Epithelial Remodeling
Nasal airway epithelium
Lamina propria Neutrophils IL-13
IL-5 EosinophilsLymphocyte
Blood vessel
1 day 9 days
Figure 3. Long-term ozone exposure effects consistent with a role for air pollution in airway inflammation and remodeling leading to asthma development.
IL-5 = interleukin-5; IL-13= interleukin-13; ILC= innate lymphoid cells. Image by Jack R. Harkema.
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remodeling in distal airway regions, which
are key to COPD airway obstruction (114–
116).
Modifiers of the Impact of Air Pollution
on Airway Disease
Interindividual variation has been
identified in susceptibility to the pulmonary
effects of air pollution, via both extrinsic
(environmental) and intrinsic (host)
factors (117). Extrinsic factors include
socioeconomic status, exposure to other
environmental stimuli, nutrition, and
coexposures/infections. Intrinsic factors
include age, sex, preexisting disease, and
genetic background. Other risk factors
include host/maternal obesity (118, 119),
diabetes and diet (120), childhood rhinovirus
and respiratory syncytial virus infections,
and psychosocial and maternal stressors
(105).
Gaps in the Evidence and
Opportunities for Future Research
Various inbred strains and genetic
models have been used to investigate
susceptibility to respiratory disease;
however, these models do not reflect the
genetic heterogeneity found in humans.
Collaborative Cross and Diversity
Outbred models more closely mimic human
genetic variability (121). Furthermore, a
number of promising animal models of
COPD have been developed (111, 112)
and used to study factors involved in
tobacco smoke–induced COPD, but not
air pollution. Because of the structural
and immunologic similarities between
humans and nonhuman primates,
long-term studies in nonhuman primates
would be fruitful (122).
Mechanistic Conclusions
d There are asthma-like phenotypes that
increase in incidence/severity with
long-term exposure to air pollution,
especially to PM and O3, consistent
with the biological plausibility of air
pollution as a causal factor in asthma
development.
d Repeated and intermittent air pollution
exposures can cause airway remodeling,
which leads to the development of
asthma, and may also lead to COPD.
d Sufficient toxicological evidence for air
pollution as a cause of COPD is still
lacking.
d There remain multiple gaps in our
knowledge about airway disease
development, including a lack of
validated mechanistic models for studies
at environmentally relevant exposure
levels, and evaluations of epigenetic and
genetic influences.
Clinical Considerations
Many of the clinical parameters considered
in a diagnosis of asthma or COPD, such
as symptoms of wheeze, cough and
mucus production, dyspnea, airway
hyperresponsiveness, reduced lung function,
and airway remodeling, are also caused by
long-term air pollution exposure (123). Air
pollution is therefore a plausible contributor
to the risk of a new clinical diagnosis of
asthma or COPD. However, there are
• Air pollution causes lung function deficits, airway remodeling, and other clinical
  parameters considered in the diagnosis of asthma and COPD
• Air pollution is a clinically plausible contributor to the development and
  diagnosis of both asthma and COPD
Clinical Considerations
Epidemiologic Evidence
• Strong evidence for childhood asthma and
  long-term air pollution exposure, especially
  TRAP as measured by NO2 and BC
• Suggestive, but insufficient, evidence for adult
  asthma and TRAP
Asthma
• Few studies of long-term air pollution exposure
   and COPD onset
• Overall, insufficient evidence
COPD
Mechanistic Evidence
• Support for biological plausibility
• Air pollution, especially PM2.5 and O3,
  demonstrated to cause airway remodeling and
  increases in incidence/severity of asthma-like
  phenotypes
Asthma
• Limited availability of appropriate animal
  models for COPD
• Overall, insufficient evidence
COPD
Workshop Conclusions
   Epidemiologic and toxicological evidence convincingly indicate a causal induction of new childhood
  asthma by long-term outdoor air pollution exposure
   Although combined evidence supports the hypothesis that air pollution is related to adult onset
  asthma and COPD, additional evidence is needed to definitively conclude a causal connection
Figure 4. Workshop findings and conclusions. BC=black carbon; COPD=chronic obstructive pulmonary disease; NO2=nitrogen dioxide;
PM2.5 = particulate matter less than or equal to 2.5 mm in aerodynamic diameter; TRAP= traffic-related air pollution.
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challenges in translating epidemiological and
toxicological findings to the clinical context.
Large observational epidemiological studies
often do not have the same information that
may be incorporated into a clinician’s
diagnostic decision. Studies of exposures to
air pollution and the risk of new-onset
asthma or COPD have generally relied on
self-reported physician diagnoses. For both
asthma and COPD, a self-reported physician
diagnosis is relatively specific but not
sensitive, and cases may be missed or
overreported in epidemiologic studies.
Additional medical information, including
medical history, response to therapeutic
medication, physical examination, and lung
function measurements, used for the
diagnosis of asthma or COPD, may be
lacking in epidemiologic studies. For
example, pre- and postbronchodilator
spirometry and/or methacholine challenge
can contribute to a diagnosis, but may not
always be included in large epidemiological
studies.
Asthma is clinically defined by a history
of intermittent respiratory symptoms (e.g.,
wheeze, shortness of breath, chest tightness,
and cough) with reversible airways
obstruction and/or hyperresponsiveness
(124). Several phenotypes (e.g., allergic and
nonallergic) and endotypes (e.g., with or
without biomarkers of enhanced Th2
response) have been described (125), and
air pollution may have differential effects
on the risk for new-onset asthma depending
on genetic susceptibility, the presence
of allergy, coexposures, obesity, age, and
sex. The etiology of asthma is likely
multifactorial, and air pollution
alone may rarely be the sole or even
primary cause.
COPD is a condition characterized by
more persistent respiratory symptoms (e.g.,
shortness of breath, chronic cough, and
sputum production), defined by fixed
airways obstruction that does not reverse
with bronchodilator administration (126).
COPD also has several phenotypes (e.g.,
chronic bronchitis and emphysema) and
endotypes (e.g., sputum with or without
eosinophils) (127). Spirometry is required
for a COPD diagnosis (112), but many
published observational studies of air
pollution exposures and COPD have not
used spirometry to define the outcome.
It is well recognized that COPD is
clinically underdiagnosed (128). Another
challenge is inadequate data to adjust
for possible confounding from smoking,
occupational exposures, or household
air pollution from combustion of solid
fuels for cooking and heating, and the
long latency period for COPD development
(52). COPD is likely multifactorial, and
air pollution is often working in
concert with other determinants of
disease risk.
Clinical Conclusions
Many of the clinical parameters
considered in a diagnosis of asthma or
COPD (e.g., lung function deficits and
airway remodeling) are also caused by
long-term air pollution exposure, as
documented above, indicating that air
pollution is a clinically plausible contributor
to the development and diagnosis of both
asthma and COPD.
Workshop Conclusions
and Recommendations
A summary of the Workshop findings
and conclusions is presented in Figure 4.
At the end of the Workshop, votes
were taken on each of the overarching
questions, and there was unanimous
agreement that:
1. There are biological mechanisms by which
air pollution could plausibly cause the
induction of new asthma and/or
COPD.
2. Air pollution’s known effects on the lung
and airways could plausibly contribute to
a diagnosis of asthma or COPD in a
clinical setting.
3. Epidemiologic and toxicological
evidence convincingly indicates a causal
link between long-term exposure to
outdoor air pollution (especially TRAP)
and new childhood asthma.
4. Based on the above, it is concluded that
there is sufficient scientific evidence to
conclude that long-term outdoor air
pollution exposure causally contributes
to the development of new childhood
asthma.
5. Although combined toxicological and
epidemiological evidence supports the
hypothesis that long-term air pollution is
related to adult-onset asthma and COPD
onset, further investigations are needed
to definitively conclude that there is a
causal connection.
Future Directions
1. Developing long-term, well-
characterized mechanistic air pollution
inhalation exposure models for asthma
and COPD.
2. Gaining a better understanding of
whether the epidemiological associations
found for TRAP are due to direct effects
of NO2, or to a component of the PM2.5
mass with which NO2 is commonly
associated (e.g., fossil-fuel combustion
fine particles).
3. Conducting further investigations of
air pollution’s impacts on the development
of COPD and adult-onset asthma. n
This official Workshop report was prepared by an
ad hoc subcommittee of the ATS Assembly on
Environmental, Occupational and Population
Health.
Members of the subcommittee are as follows:
GEORGE D. THURSTON, Sc.D. (Chair)1*
JOHN R. BALMES, M.D. (Writing Committee)2,3*
ERIKA GARCIA, M.D. (Writing Committee)4*
FRANK D. GILLILAND, M.D., PH.D. (Writing
Committee)4*
MARY B. RICE, M.D., M.P.H. (Writing Committee)5*
TAMARA SCHIKOWSKI, PH.D., M.P.H. (Writing
Committee)6*
LAURA S. VAN WINKLE, PH.D. (Writing Committee)7*
ISABELLA ANNESI-MAESANO, PH.D.8
ESTEBAN G. BURCHARD, M.D., PH.D.2
CHRISTOPHER CARLSTEN, M.D.9
JACK R. HARKEMA, D.V.M., PH.D.10
HANEEN KHREIS, PH.D.11
STEVEN R. KLEEBERGER, PH.D.12
URMILA P. KODAVANTI, PH.D.13
STEPHANIE J. LONDON, M.D., DR.P.H.14
ROB MCCONNELL, M.D.4
DAVE B. PEDEN, M.D., M.S.15
KENT E. PINKERTON, PH.D., M.S.7
JOAN REIBMAN, M.D.1
CARL W. WHITE, M.D.16
1New York University School of Medicine,
New York, New York; 2University of California,
San Francisco, San Francisco, California;
3University of California, Berkeley, Berkeley,
California; 4Keck School of Medicine, University
of Southern California, Los Angeles, California;
5Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Massachusetts; 6IUF-
Leibniz Research Institute of Environmental
Medicine, Duesseldorf, Germany; 7University of
California, Davis, California; 8Sorbonne
University, Paris, France; 9University of British
Columbia, Vancouver, British Columbia, Canada;
10Michigan State University, East Lansing,
Michigan; 11Texas A&M Transportation
Institute, College Station, Texas; 12Genetics,
Environment & Respiratory Disease Group
and 14Department of Health and Human
Services, National Institute of Environmental
Health Sciences, Research Triangle Park,
North Carolina; 13Center for Public Health
AMERICAN THORACIC SOCIETY DOCUMENTS
394 AnnalsATS Volume 17 Number 4| April 2020
and Environmental Assessment, Environmental
Protection Agency, Research Triangle
Park, North Carolina; 15Gillings School
of Global Public Health, University of North
Carolina, Chapel Hill, North Carolina; and
16University of Colorado Denver, Denver,
Colorado.
*Members of the writing committee.
Author Disclosures: J.R.B. is the Physician
Member of the California Air Resources Board.
M.B.R. received research support from the NIH.
L.S.V.W. has ownership or investment interests
with Amgen; received research support from the
Chloropicrin Manufacturers Association. C.C.
served on an advisory committee for Bayer;
received research support and served on an
advisory committee for GlaxoSmithKline. D.B.P.
received research support from the EPA and the
NIEHS. J.R. served as a consultant for Novartis;
served on an advisory committee for AstraZeneca
and Genentech; received research support from
the American Lung Association and the CDC-
NIOSH. G.D.T., E.G., F.D.G., T.S., I.A.-M.,
E.G.B., J.R.H., H.K., S.R.K., U.P.K., S.J.L.,
R.M., K.E.P., and C.W.W. reported no
relationships with relevant commercial interests.
References
1 U.S. Environmental Protection Agency. Integrated science assessment
for particulate matter (EPA/600/R-08/139F). Washington, DC: U.S.
Environmental Protection Agency; 2009.
2 U.S. Environmental Protection Agency. Integrated Science
Assessment of Ozone and Related Photochemical Oxidants (PA/
600/R-10/076F). Washington, DC: U.S. Environmental Protection
Agency; 2013.
3 U.S. Environmental Protection Agency. Integrated science assessment
for oxides of nitrogen—health criteria (EPA/600/R-15/068).
Washington, DC: U.S. Environmental Protection Agency; 2016.
4 U.S. Environmental Protection Agency. Integrated science assessment
for sulfur oxides—health criteria (EPA/600/R-17/451). Washington,
DC: U.S. Environmental Protection Agency; 2017.
5 Ostro B, Lipsett M, Mann J, Braxton-Owens H, White M. Air pollution
and exacerbation of asthma in African-American children in Los
Angeles. Epidemiology 2001;12:200–208.
6 Gent JF, Triche EW, Holford TR, Belanger K, Bracken MB, Beckett WS,
et al. Association of low-level ozone and fine particles with
respiratory symptoms in children with asthma. JAMA 2003;290:
1859–1867.
7 Gilliland FD, Berhane K, Rappaport EB, Thomas DC, Avol E,
Gauderman WJ, et al. The effects of ambient air pollution on school
absenteeism due to respiratory illnesses. Epidemiology 2001;12:
43–54.
8 Bates DV. The effects of air pollution on children. Environ Health
Perspect 1995;103:49–53.
9 Strickland MJ, Darrow LA, Klein M, Flanders WD, Sarnat JA, Waller LA,
et al. Short-term associations between ambient air pollutants and
pediatric asthma emergency department visits. Am J Respir Crit
Care Med 2010;182:307–316.
10 Mar TF, Koenig JQ, Primomo J. Associations between asthma
emergency visits and particulate matter sources, including diesel
emissions from stationary generators in Tacoma, Washington. Inhal
Toxicol 2010;22:445–448.
11 Sheffield PE, Zhou J, Shmool JL, Clougherty JE. Ambient ozone
exposure and children’s acute asthma in New York City: a case-
crossover analysis. Environ Health 2015;14:25.
12 Chen K, Glonek G, Hansen A, Williams S, Tuke J, Salter A, et al. The
effects of air pollution on asthma hospital admissions in Adelaide,
South Australia, 2003–2013: time-series and case-crossover
analyses. Clin Exp Allergy 2016;46:1416–1430.
13 Spektor DM, Thurston GD,Mao J, He D, Hayes C, LippmannM. Effects
of single- and multiday ozone exposures on respiratory function in
active normal children. Environ Res 1991;55:107–122.
14 Spira-Cohen A, Chen LC, Kendall M, Lall R, Thurston GD. Personal
exposures to traffic-related air pollution and acute respiratory health
among Bronx schoolchildren with asthma. Environ Health Perspect
2011;119:559–565.
15 Balmes JR, Earnest G, Katz PP, Yelin EH, Eisner MD, Chen H, et al.
Exposure to traffic: lung function and health status in adults with
asthma. J Allergy Clin Immunol 2009;123:626–631.
16 Ierodiakonou D, Zanobetti A, Coull BA, Melly S, Postma DS, Boezen
HM, et al.; Childhood Asthma Management Program Research
Group. Ambient air pollution, lung function, and airway
responsiveness in asthmatic children. J Allergy Clin Immunol 2016;
137:390–399.
17 Garshick E. Effects of short- and long-term exposures to ambient air
pollution on COPD. Eur Respir J 2014;44:558–561.
18 Weichenthal SA, Lavigne E, Evans GJ, Godri Pollitt KJ, Burnett RT. Fine
particulate matter and emergency room visits for respiratory illness.
Effect modification by oxidative potential. Am J Respir Crit Care Med
2016;194:577–586.
19 Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al.
Fine particulate air pollution and hospital admission for
cardiovascular and respiratory diseases. JAMA 2006;295:
1127–1134.
20 Li MH, Fan LC, Mao B, Yang JW, Choi AMK, Cao WJ, et al. Short-term
exposure to ambient fine particulate matter increases
hospitalizations and mortality in COPD: a systematic review and
meta-analysis. Chest 2016;149:447–458.
21 Health Effects Institute. Traffic-related air pollution: a critical review of
the literature on emissions, exposure, and health effects; 2010.
22 McConnell R, Islam T, Shankardass K, Jerrett M, Lurmann F, Gilliland F,
et al. Childhood incident asthma and traffic-related air pollution at
home and school. Environ Health Perspect 2010;118:1021–1026.
23 Khreis H, Kelly C, Tate J, Parslow R, Lucas K, Nieuwenhuijsen M.
Exposure to traffic-related air pollution and risk of development of
childhood asthma: a systematic review and meta-analysis. Environ
Int 2017;100:1–31.
24 Hehua Z, Qing C, Shanyan G, Qijun W, Yuhong Z. The impact of
prenatal exposure to air pollution on childhood wheezing and
asthma: A systematic review. Environ Res 2017;159:519–530.
25 Lee JY, Leem JH, Kim HC, Lamichhane DK, Hwang SS, Kim JH, et al.
Effects of traffic-related air pollution on susceptibility to infantile
bronchiolitis and childhood asthma: a cohort study in Korea. J
Asthma 2018;55:223–230.
26 Pennington AF, Strickland MJ, Klein M, Zhai X, Bates JT, Drews-
Botsch C, et al. Exposure to mobile source air pollution in early-life
and childhood asthma incidence: the Kaiser Air Pollution and
Pediatric Asthma Study. Epidemiology 2018;29:22–30.
27 Rancie`re F, Bougas N, Viola M, Momas I. Early exposure to traffic-
related air pollution, respiratory symptoms at 4 years of age, and
potential effect modification by parental allergy, stressful family
events, and sex: a prospective follow-up study of the PARIS birth
cohort. Environ Health Perspect 2017;125:737–745.
28 Rice MB, Rifas-Shiman SL, Litonjua AA, Gillman MW, Liebman N,
Kloog I, et al. Lifetime air pollution exposure and asthma in a
pediatric birth cohort. J Allergy Clin Immunol 2018;141:
1932–1934.e7.
29 Lavigne E´, Be´lair MA, Rodriguez Duque D, DoMT, Stieb DM, Hystad P,
et al. Effect modification of perinatal exposure to air pollution and
childhood asthma incidence. Eur Respir J 2018;pii:1701884.
30 Te´treault LF, Doucet M, Gamache P, Fournier M, Brand A, Kosatsky T,
et al. Childhood exposure to ambient air pollutants and the onset of
asthma: an administrative cohort study in Que´bec. Environ Health
Perspect 2016;124:1276–1282.
31 Yang A, Janssen NA, Brunekreef B, Cassee FR, Hoek G, Gehring U.
Children’s respiratory health and oxidative potential of PM2.5: the
PIAMA birth cohort study. Occup Environ Med 2016;73:154–160.
32 Deng Q, Lu C, Li Y, Sundell J, Dan Norba¨ck. Exposure to outdoor air
pollution during trimesters of pregnancy and childhood asthma,
allergic rhinitis, and eczema. Environ Res 2016;150:119–127.
33 Jung CR, Chen WT, Tang YH, Hwang BF. Fine particulate matter
exposure during pregnancy and infancy and incident asthma. J
Allergy Clin Immunol 2019;143:2254–2262.e5.
34 Mott L. The disproportionate impact of environmental health threats on
children of color. Environ Health Perspect 1995;103:33–35.
AMERICAN THORACIC SOCIETY DOCUMENTS
American Thoracic Society Documents 395
35 Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA,
et al. Trends in asthma prevalence, health care use, and mortality in
the United States, 2001–2010. NCHS Data Brief 2012;(94):1–8.
36 Nishimura KK, Galanter JM, Roth LA, Oh SS, Thakur N, Nguyen EA,
et al. Early-life air pollution and asthma risk in minority children. The
GALA II and SAGE II studies. Am J Respir Crit Care Med 2013;188:
309–318.
37 Garcia E, Berhane KT, Islam T, McConnell R, Urman R, Chen Z, et al.
Association of changes in air quality with incident asthma in children
in California, 1993–2014. JAMA 2019;321:1906–1915.
38 Anderson H, Favarato G, Atkinson R. Long-term exposure to outdoor
air pollution and the prevalence of asthma: meta-analysis of multi-
community prevalence studies. Air Qual Atmos Health 2013;6:
57–68.
39 Jacquemin B, Schikowski T, Carsin AE, Hansell A, Kra¨mer U, Sunyer J,
et al. The role of air pollution in adult-onset asthma: a review of the
current evidence. Semin Respir Crit Care Med 2012;33:606–619.
40 Bowatte G, Lodge CJ, Knibbs LD, Erbas B, Perret JL, Jalaludin B, et al.
Traffic related air pollution and development and persistence of
asthma and low lung function. Environ Int 2018;113:170–176.
41 Young MT, Sandler DP, DeRoo LA, Vedal S, Kaufman JD, London SJ.
Ambient air pollution exposure and incident adult asthma in a
nationwide cohort of U.S. women. Am J Respir Crit Care Med 2014;
190:914–921.
42 Jacquemin B, Siroux V, Sanchez M, Carsin AE, Schikowski T, AdamM,
et al. Ambient air pollution and adult asthma incidence in six
European cohorts (ESCAPE). Environ Health Perspect 2015;123:
613–621.
43 Anderson HR, Favarato G, Atkinson RW. Long-term exposure to air
pollution and the incidence of asthma: meta-analysis of cohort
studies. Air Qual Atmos Health 2013;6:47–56.
44 Fisher JE, Loft S, Ulrik CS, Raaschou-Nielsen O, Hertel O, Tjønneland
A, et al. Physical activity, air pollution, and the risk of asthma and
chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2016;194:855–865.
45 Weichenthal S, Bai L, Hatzopoulou M, Van Ryswyk K, Kwong JC,
Jerrett M, et al. Long-term exposure to ambient ultrafine particles
and respiratory disease incidence in in Toronto, Canada: a cohort
study. Environ Health 2017;16:64.
46 McDonnell WF, Abbey DE, Nishino N, Lebowitz MD. Long-term
ambient ozone concentration and the incidence of asthma in
nonsmoking adults: the AHSMOG Study. Environ Res 1999;80:
110–121.
47 Hwang BF, Lee YL, Lin YC, Jaakkola JJ, Guo YL. Traffic related air
pollution as a determinant of asthma among Taiwanese school
children. Thorax 2005;60:467–473.
48 McConnell R, Berhane K, Gilliland F, London SJ, Islam T, Gauderman
WJ, et al. Asthma in exercising children exposed to ozone: a cohort
study. Lancet 2002;359:386–391.
49 ClevelandWS, Graedel TE. Photochemical air pollution in the northeast
United States. Science 1979;204:1273–1278.
50 Carlsten C, Dybuncio A, Becker A, Chan-Yeung M, Brauer M. Traffic-
related air pollution and incident asthma in a high-risk birth cohort.
Occup Environ Med 2011;68:291–295.
51 Gehring U, Beelen R, Eeftens M, Hoek G, de Hoogh K, de Jongste JC,
et al. Particulate matter composition and respiratory health: the
PIAMA birth cohort study. Epidemiology 2015;26:300–309.
52 Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R,
Postma D, et al.; Committee on Nonsmoking COPD, Environmental
and Occupational Health Assembly. An official American Thoracic
Society public policy statement: novel risk factors and the global
burden of chronic obstructive pulmonary disease. Am J Respir Crit
Care Med 2010;182:693–718.
53 Abbey DE, Ostro BE, Petersen F, Burchette RJ. Chronic respiratory
symptoms associated with estimated long-term ambient
concentrations of fine particulates less than 2.5 microns in
aerodynamic diameter (PM2.5) and other air pollutants. J Expo Anal
Environ Epidemiol 1995;5:137–159.
54 Hooper LG, Young MT, Keller JP, Szpiro AA, O’Brien KM, Sandler DP,
et al. Ambient air pollution and chronic bronchitis in a cohort of U.S.
women. Environ Health Perspect 2018;126:027005.
55 Sunyer J, Jarvis D, Gotschi T, Garcia-Esteban R, Jacquemin B,
Aguilera I, et al. Chronic bronchitis and urban air pollution in an
international study. Occup Environ Med 2006;63:836–843.
56 Schikowski T, Adam M, Marcon A, Cai Y, Vierko¨tter A, Carsin AE, et al.
Association of ambient air pollution with the prevalence and
incidence of COPD. Eur Respir J 2014;44:614–626.
57 Andersen ZJ, Hvidberg M, Jensen SS, Ketzel M, Loft S, Sørensen M,
et al. Chronic obstructive pulmonary disease and long-term
exposure to traffic-related air pollution: a cohort study. Am J Respir
Crit Care Med 2011;183:455–461.
58 Atkinson RW, Carey IM, Kent AJ, van Staa TP, Anderson HR, Cook DG.
Long-term exposure to outdoor air pollution and the incidence of
chronic obstructive pulmonary disease in a national English cohort.
Occup Environ Med 2015;72:42–48.
59 Carey IM, Anderson HR, Atkinson RW, Beevers S, Cook DG, Dajnak D,
et al. Traffic pollution and the incidence of cardiorespiratory
outcomes in an adult cohort in London.Occup EnvironMed 2016;73:
849–856.
60 To T, Zhu J, Larsen K, Simatovic J, Feldman L, Ryckman K, et al.;
Canadian Respiratory Research Network. Progression from asthma
to chronic obstructive pulmonary disease. Is air pollution a risk
factor? Am J Respir Crit Care Med 2016;194:429–438.
61 Pathak U, Gupta NC, Suri JC. Risk of COPD due to indoor air pollution
from biomass cooking fuel: a systematic review and meta-analysis.
Int J Environ Health Res 2020;30:75–88.
62 Hill AB. The environment and disease: association or causation? Proc
R Soc Med 1965;58:295–300.
63 Thurston GD, Kipen H, Annesi-Maesano I, Balmes J, Brook RD, Cromar
K, et al. A joint ERS/ATS policy statement: what constitutes an
adverse health effect of air pollution? An analytical framework. Eur
Respir J 2017;49:1600419.
64 Martinez FD. The origins of asthma and chronic obstructive pulmonary
disease in early life. Proc Am Thorac Soc 2009;6:272–277.
65 Evans MJ, Van Winkle LS, Fanucchi MV, Plopper CG. The attenuated
fibroblast sheath of the respiratory tract epithelial-mesenchymal
trophic unit. Am J Respir Cell Mol Biol 1999;21:655–657.
66 Herring MJ, Putney LF, Wyatt G, Finkbeiner WE, Hyde DM. Growth of
alveoli during postnatal development in humans based on
stereological estimation. Am J Physiol Lung Cell Mol Physiol 2014;
307:L338–L344.
67 Hyde DM, Blozis SA, Avdalovic MV, Putney LF, Dettorre R,
Quesenberry NJ, et al. Alveoli increase in number but not size from
birth to adulthood in rhesus monkeys. Am J Physiol Lung Cell Mol
Physiol 2007;293:L570–L579.
68 Lee D, Wallis C, Wexler AS, Schelegle ES, Van Winkle LS, Plopper CG,
et al. Small particles disrupt postnatal airway development. J Appl
Physiol (1985) 2010;109:1115–1124.
69 Lee D, Wallis C, Van Winkle LS, Wexler AS. Disruption of
tracheobronchial airway growth following postnatal exposure to
ozone and ultrafine particles. Inhal Toxicol 2011;23:520–531.
70 Fanucchi MV, Plopper CG, Evans MJ, Hyde DM, Van Winkle LS,
Gershwin LJ, et al. Cyclic exposure to ozone alters distal airway
development in infant rhesus monkeys. Am J Physiol Lung Cell Mol
Physiol 2006;291:L644–L650.
71 Mauad T, Rivero DH, de Oliveira RC, Lichtenfels AJ, Guimarães ET, de
Andre PA, et al. Chronic exposure to ambient levels of urban
particles affects mouse lung development. Am J Respir Crit Care
Med 2008;178:721–728.
72 Avdalovic MV, Tyler NK, Putney L, Nishio SJ, Quesenberry S, Singh PJ,
et al. Ozone exposure during the early postnatal period alters the
timing and pattern of alveolar growth and development in nonhuman
primates. Anat Rec (Hoboken) 2012;295:1707–1716.
73 Chan JK, Fanucchi MV, Anderson DS, Abid AD, Wallis CD, Dickinson
DA, et al. Susceptibility to inhaled flame-generated ultrafine soot in
neonatal and adult rat lungs. Toxicol Sci 2011;124:472–486.
74 Schelegle ES, Miller LA, Gershwin LJ, Fanucchi MV, Van Winkle LS,
Gerriets JE, et al. Repeated episodes of ozone inhalation amplifies
the effects of allergen sensitization and inhalation on airway immune
and structural development in rhesus monkeys. Toxicol Appl
Pharmacol 2003;191:74–85.
AMERICAN THORACIC SOCIETY DOCUMENTS
396 AnnalsATS Volume 17 Number 4| April 2020
75 Herring MJ, Putney LF, St George JA, Avdalovic MV, Schelegle ES,
Miller LA, et al. Early life exposure to allergen and ozone results in
altered development in adolescent rhesus macaque lungs. Toxicol
Appl Pharmacol 2015;283:35–41.
76 Moore BD, Hyde DM, Miller LA, Wong EM, Schelegle ES. Persistence
of serotonergic enhancement of airway response in a model of
childhood asthma. Am J Respir Cell Mol Biol 2014;51:77–85.
77 Deiuliis JA, Kampfrath T, Zhong J, Oghumu S, Maiseyeu A, Chen LC,
et al. Pulmonary T cell activation in response to chronic particulate air
pollution. Am J Physiol Lung Cell Mol Physiol 2012;302:L399–L409.
78 Wan G, Rajagopalan S, Sun Q, Zhang K. Real-world exposure of
airborne particulate matter triggers oxidative stress in an animal
model. Int J Physiol Pathophysiol Pharmacol 2010;2:64–68.
79 Li YJ, Kawada T, Takizawa H, Azuma A, Kudoh S, Sugawara I, et al.
Airway inflammatory responses to oxidative stress induced by
prolonged low-dose diesel exhaust particle exposure from birth
differ between mouse BALB/c and C57BL/6 strains. Exp Lung Res
2008;34:125–139.
80 Weldy CS, Luttrell IP, White CC, Morgan-Stevenson V, Cox DP,
Carosino CM, et al. Glutathione (GSH) and the GSH synthesis gene
Gclm modulate plasma redox and vascular responses to acute
diesel exhaust inhalation in mice. Inhal Toxicol 2013;25:444–454.
81 McDonald JD, Doyle-Eisele M, Gigliotti A, Miller RA, Seilkop S,
Mauderly JL, et al.; HEI Health Review Committee. Part 1. Biologic
responses in rats andmice to subchronic inhalation of diesel exhaust
from US 2007-compliant engines: report on 1-, 3-, and 12-month
exposures in the ACES bioassay. Res Rep Health Eff Inst 2012;166:
9–120.
82 Pinkerton KE, Zhou Y, Zhong C, Smith KR, Teague SV, Kennedy IM,
et al. Mechanisms of particulate matter toxicity in neonatal and
young adult rat lungs. Res Rep Health Eff Inst 2008;135:3–41;
discussion 43–52.
83 Wan Q, Cui X, Shao J, Zhou F, Jia Y, Sun X, et al. Beijing ambient
particle exposure accelerates atherosclerosis in ApoE knockout
mice by upregulating visfatin expression. Cell Stress Chaperones
2014;19:715–724.
84 Alessandrini F,Weichenmeier I, vanMiert E, Takenaka S, Karg E, Blume
C, et al. Effects of ultrafine particles-induced oxidative stress on
Clara cells in allergic lung inflammation.Part Fibre Toxicol 2010;7:11.
85 Dick CA, Singh P, Daniels M, Evansky P, Becker S, Gilmour MI. Murine
pulmonary inflammatory responses following instillation of size-
fractionated ambient particulate matter. J Toxicol Environ Health A
2003;66:2193–2207.
86 Van Winkle LS, Chan JK, Anderson DS, Kumfer BM, Kennedy IM,
Wexler AS, et al. Age specific responses to acute inhalation of
diffusion flame soot particles: cellular injury and the airway
antioxidant response. Inhal Toxicol 2010;22:70–83.
87 Chan JK, Charrier JG, Kodani SD, Vogel CF, Kado SY, Anderson DS,
et al. Combustion-derived flame generated ultrafine soot generates
reactive oxygen species and activates Nrf2 antioxidants differently in
neonatal and adult rat lungs. Part Fibre Toxicol 2013;10:34.
88 Chan JK, Kodani SD, Charrier JG, Morin D, Edwards PC, Anderson DS,
et al. Age-specific effects on rat lung glutathione and antioxidant
enzymes after inhaling ultrafine soot. Am J Respir Cell Mol Biol 2013;
48:114–124.
89 Chan JK, Vogel CF, Baek J, Kodani SD, Uppal RS, Bein KJ, et al.
Combustion derived ultrafine particles induce cytochrome P-450
expression in specific lung compartments in the developing neonatal
and adult rat. Am J Physiol Lung Cell Mol Physiol 2013;304:
L665–L677.
90 Steerenberg PA, van Dalen WJ, Withagen CE, Dormans JA, van
Loveren H. Optimization of route of administration for coexposure to
ovalbumin and particle matter to induce adjuvant activity in
respiratory allergy in the mouse. Inhal Toxicol 2003;15:1309–1325.
91 Gilmour MI, Selgrade MJ, Lambert AL. Enhanced allergic sensitization
in animals exposed to particulate air pollution. Inhal Toxicol 2000;12:
373–380.
92 Løvik M, Høgseth AK, Gaarder PI, Hagemann R, Eide I. Diesel exhaust
particles and carbon black have adjuvant activity on the local lymph
node response and systemic IgE production to ovalbumin.
Toxicology 1997;121:165–178.
93 SamuelsenM, Nygaard UC, LøvikM. Allergy adjuvant effect of particles
from wood smoke and road traffic. Toxicology 2008;246:124–131.
94 de Haar C, Kool M, Hassing I, Bol M, Lambrecht BN, Pieters R. Lung
dendritic cells are stimulated by ultrafine particles and play a key role
in particle adjuvant activity. J Allergy Clin Immunol 2008;121:
1246–1254.
95 Xia T, Zhu Y, Mu L, Zhang ZF, Liu S. Pulmonary diseases induced by
ambient ultrafine and engineered nanoparticles in twenty-first
century. Natl Sci Rev 2016;3:416–429.
96 Alberg T, Hansen JS, Lovik M, Nygaard UC. Particles influence allergic
responses in mice—role of gender and particle size. J Toxicol
Environ Health A 2014;77:281–292.
97 Falcon-Rodriguez CI, De Vizcaya-Ruiz A, Rosas-Pe´rez IA, Osornio-
Vargas AR, Segura-Medina P. Inhalation of concentrated PM2.5 from
Mexico City acts as an adjuvant in a guinea pig model of allergic
asthma. Environ Pollut 2017;228:474–483.
98 Castañeda AR, Bein KJ, Smiley-Jewell S, Pinkerton KE. Fine
particulate matter (PM2.5) enhances allergic sensitization in BALB/c
mice. J Toxicol Environ Health A 2017;80:197–207.
99 Harkema JR, Keeler G, Wagner J, Morishita M, Timm E, Hotchkiss J,
et al. Effects of concentrated ambient particles on normal and
hypersecretory airways in rats. Res Rep Health Eff Inst 2004:120:
1–68; discussion 69–79.
100 Gavett SH, Haykal-Coates N, Copeland LB, Heinrich J, Gilmour MI.
Metal composition of ambient PM2.5 influences severity of allergic
airways disease in mice. Environ Health Perspect 2003;111:
1471–1477.
101 Salam MT, Lin PC, Avol EL, Gauderman WJ, Gilliland FD. Microsomal
epoxide hydrolase, glutathione S-transferase P1, traffic and
childhood asthma. Thorax 2007;62:1050–1057.
102 Ong CB, Kumagai K, Brooks PT, Brandenberger C, Lewandowski RP,
Jackson-Humbles DN, et al. Ozone-induced type 2 immunity in nasal
airways. development and lymphoid cell dependence in mice. Am J
Respir Cell Mol Biol 2016;54:331–340.
103 Kumagai K, Lewandowski R, Jackson-Humbles DN, Li N, Van Dyken
SJ, Wagner JG, et al. Ozone-induced nasal type 2 immunity in mice
is dependent on innate lymphoid cells. Am J Respir Cell Mol Biol
2016;54:782–791.
104 Kumagai K, Lewandowski RP, Jackson-Humbles DN, Buglak N, Li N,
White K, et al. Innate lymphoid cells mediate pulmonary eosinophilic
inflammation, airwaymucous cell metaplasia, and type 2 immunity in
mice exposed to ozone. Toxicol Pathol 2017;45:692–704.
105 Harkema JR, Hotchkiss LA, Vetter NA, Jackson-Humbles DN,
Lewandowski RP, Wagner JG. Strain differences in a murine model
of air pollutant-induced nonatopic asthma and rhinitis. Toxicol
Pathol 2017;45:161–171.
106 Frischer T, Studnicka M, Halmerbauer G, Horak F Jr, Gartner C, Tauber
E, et al. Ambient ozone exposure is associated with eosinophil
activation in healthy children. Clin Exp Allergy 2001;31:1213–1219.
107 Nishimura KK, Iwanaga K, Oh SS, Pino-Yanes M, Eng C, Keswani A,
et al. Early-life ozone exposure associated with asthma without
sensitization in Latino children. J Allergy Clin Immunol 2016;138:
1703–1706.e1.
108 Muñoz X, Barreiro E, Bustamante V, Lopez-Campos JL, Gonza´lez-
Barcala FJ, Cruz MJ. Diesel exhausts particles: their role in
increasing the incidence of asthma. Reviewing the evidence of a
causal link. Sci Total Environ 2019;652:1129–1138.
109 Jones B, Donovan C, Liu G, Gomez HM, Chimankar V, Harrison CL,
et al. Animal models of COPD: what do they tell us? Respirology
2017;22:21–32.
110 Huang G, Xu XC, Zhou JS, Li ZY, Chen HP, Wang Y, et al. Neutrophilic
inflammation in the immune responses of chronic obstructive
pulmonary disease: lessons from animal models. J Immunol Res
2017;2017:7915975.
111 Bolton SJ, Pinnion K, Oreffo V, Foster M, Pinkerton KE.
Characterisation of the proximal airway squamous metaplasia
induced by chronic tobacco smoke exposure in spontaneously
hypertensive rats. Respir Res 2009;10:118.
112 Raju SV, Kim H, Byzek SA, Tang LP, Trombley JE, Jackson P, et al. A
ferret model of COPD-related chronic bronchitis. JCI Insight 2016;1:
e87536.
AMERICAN THORACIC SOCIETY DOCUMENTS
American Thoracic Society Documents 397
113 Kodavanti UP, Schladweiler MC, Ledbetter AD, Watkinson WP,
Campen MJ, Winsett DW, et al. The spontaneously hypertensive rat
as a model of human cardiovascular disease: evidence of
exacerbated cardiopulmonary injury and oxidative stress from
inhaled emission particulate matter. Toxicol Appl Pharmacol 2000;
164:250–263.
114 Tyler WS, Tyler NK, Last JA, Gillespie MJ, Barstow TJ. Comparison of
daily and seasonal exposures of young monkeys to ozone.
Toxicology 1988;50:131–144.
115 Harkema JR, Hotchkiss JA. Ozone- and endotoxin-induced mucous
cell metaplasias in rat airway epithelium: novel animal models to
study toxicant-induced epithelial transformation in airways. Toxicol
Lett 1993;68:251–263.
116 Hyde DM, Plopper CG,Weir AJ, Murnane RD,Warren DL, Last JA, et al.
Peribronchiolar fibrosis in lungs of cats chronically exposed to diesel
exhaust. Lab Invest 1985;52:195–206.
117 Hooper LG, Kaufman JD. Ambient air pollution and clinical implications
for susceptible populations. Ann Am Thorac Soc 2018;15:S64–S68.
118 Moon KY, Park MK, Leikauf GD, Park CS, Jang AS. Diesel exhaust
particle-induced airway responses are augmented in obese rats. Int
J Toxicol 2014;33:21–28.
119 Gordon CJ, Phillips PM, Johnstone AFM, Schmid J, Schladweiler MC,
Ledbetter A, et al. Effects of maternal high-fat diet and sedentary
lifestyle on susceptibility of adult offspring to ozone exposure in rats.
Inhal Toxicol 2017;29:239–254.
120 Snow SJ, ChengWY, Henriquez A, HodgeM, Bass V, Nelson GM, et al.
Ozone-induced vascular contractility and pulmonary injury are
differentially impacted by diets enriched with coconut oil, fish oil, and
olive oil. Toxicol Sci 2018;163:57–69.
121 Roberts A, Pardo-Manuel de Villena F, Wang W, McMillan L, Threadgill
DW. The polymorphism architecture of mouse genetic resources
elucidated using genome-wide resequencing data: implications for
QTL discovery and systems genetics. Mamm Genome 2007;18:
473–481.
122 Plopper CG, Hyde DM. The non-human primate as a model for studying
COPD and asthma. Pulm Pharmacol Ther 2008;21:755–766.
123 National Asthma Education and Prevention Program. Expert Panel
Report 3 (EPR-3): guidelines for the diagnosis and management of
asthma—summary report 2007. J Allergy Clin Immunol 2007;120(5,
Suppl)S94–S138.
124 Global Initiative for Asthma. Global strategy for asthma management
and prevention; 2018.
125 Wenzel SE. Asthma phenotypes: the evolution from clinical to
molecular approaches. Nat Med 2012;18:716–725.
126 Global Initiative for Chronic Obstructive Lung Disease. Global strategy
for the diagnosis, management and prevention of chronic
obstructive pulmonary disease; 2018.
127 Barker BL, Brightling CE. Phenotyping the heterogeneity of
chronic obstructive pulmonary disease. Clin Sci (Lond) 2013;124:
371–387.
128 Hangaard S, Kronborg T, Hejlesen OK. Characteristics of subjects with
undiagnosed COPD based on post-bronchodilator spirometry data.
Respir Care 2019;64:63–70.
AMERICAN THORACIC SOCIETY DOCUMENTS
398 AnnalsATS Volume 17 Number 4| April 2020
